RxDoctor Payments Data

Douglas Walker

Optometrist · Brookings, ORNPI 1902806375

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,798 of the $23,129 with a category attached, or 98.6%. Johnson & Johnson Vision Care, Inc. accounts for 98.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $22,806 and has fallen 99.3% since, to $154 in 2024. Among optometrist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,129in general payments, 2019–2025

Across 14 payments — averaging $1652.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$23K
  • LKC Technologies, Inc.$167
  • Maculogix, Inc.$99
  • Coopervision Inc.$85
  • E.r. Squibb & Sons, L.L.C.$16
  • Optos, Inc.$15

What the payments were for

  • Speaking & faculty fees$22,79899%
  • Food & beverage$3171%
  • Entertainment$150%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$23,129 in reported general payments places this provider in the 95th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon

Medicare billing

Part B allowed, 2024
$144,698
Medicare patients
465
Services billed
2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost94$1,387
Prednisolone Acetate29$996
Timolol Maleate18$247

Paid to pharmacies, not to this prescriber.

Other optometrist in Brookings

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →